Sphera Funds Management Ltd. 13D and 13G filings for Inozyme Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-05 09:12 am Sale |
2023-12-31 | 13G | Inozyme Pharma, Inc. INZY |
Sphera Funds Management Ltd. | 1,562,907 2.530% |
-533,351 (-25.44%) |
Filing |
| 2023-03-07 06:01 am Purchase |
2023-03-03 | 13G | Inozyme Pharma, Inc. INZY |
Sphera Funds Management Ltd. | 2,096,258 5.190% |
2,096,258 (New Position) |
Filing |